Impact on Patient COmpliance With Medication Using Pre-packaged Blisters for Long-term Medical therapY
NCT ID: NCT04236817
Last Updated: 2023-07-19
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
NA
Total Enrollment
114 participants
Study Classification
INTERVENTIONAL
Study Start Date
2015-01-01
Study Completion Date
2015-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The use of packaging interventions like pillboxes or blister packs has been shown to significantly improve medication adherence. The purpose of this study is to assess the effect of home-delivered pill packs on medication adherence in a low-income population. This is an open-lab randomized controlled trial taking four or more medication doses daily, randomized either to the intervention group or the control group. Patients in the intervention group received prescriptions pre-packaged in individual packets that were delivered by the pharmacy. Patients in the control group continued to receive medications from pharmacies as they did prior to enrollment. The primary outcome was the percentage of missed pills in the intervention group versus the control group after four months of enrollment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thinking Outside the Box
NCT04713215
Medication Compliance
Medication Adherence
Caregivers
+1 more
COMPLETED
Improving Medication Adherence: A Study With Talking Pill Bottles
NCT02827773
Medication Adherence
COMPLETED
NA
Evaluating the Effectiveness of a Computerized Medication Adherence System at Reducing Cardiovascular Disease Risk Factors
NCT00796172
Cardiovascular Diseases
COMPLETED
PHASE2
The Influence of a Medication Adherence Smartphone Application on Medication Adherence in Chronic Illness
NCT05098743
Medication Adherence
Self Efficacy
COMPLETED
NA
Financial Incentives for Medication Adherence
NCT01678183
Diabetes Mellitus
Hypertension
Hyperlipidemia
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For patients in the study group, new prescriptions with three refills were electronically scripted to local compliance packaging pharmacy, ExactCare pharmacy, LLC, Valley View, Ohio, 44125. ExactCare is a local packaging pharmacy that pre-packs medications for patients so that each day's medications come in a separate paper compartment that can be discarded after daily use. They also deliver medications to the patients' homes. At the initiation of the study, ExactCare provided medications in pill packs for all patient medications in a 30-day supply (Figure 2). Pill bottle medications were provided for medications that would run out prior to the initial supply date. Inhalers, nebulizers, injectable medications, as needed medications and medications that required frequent dose changes were not included in the pill packs but were sent separately within the 30-day supply box.
If the patient was started on a new medication by their PCP, the local compliance packaging pharmacy packed this medication in pill packs for the next 30-day box supply and sent pill bottles containing enough pills to last the patient till the next 30-day box. Every pill in the pill pack was coded with an identification number. If the patient's physician discontinued or changed the dose of any medication, the patient was advised to remove the pill from the pack using its identification number and either discard it or make the dose change accordingly.
A study investigator counted the pills left in the control group prior to the study start date. After the study start date, patients in the control group continued to receive their medications the same way they were getting them before being enrolled in this study using either electronic or printed prescriptions. They received instructions about the timing and frequency of medication administration from their physicians and nurses, and picked up their medications from their local pharmacy.
Patients from both groups had a follow-up PCP visit approximately four months from enrollment. Patients received telephone calls prior to their follow-up appointments to remind them to bring their medications from home. During the appointment, the study investigator counted the medications remaining in the pill packs for the study group patients and the pills remaining in pill bottles for the control group patients.
ExactCare provided the initial start date for each patient receiving their pill packs in 30-day supply. Refill dates were accessed from local pharmacies and the EMR for patients in the control group. This information was used to calculate the number of pills expected to remain with each patient at the end of the study and to compare to the actual number of pills remaining. New medications, discontinued medications, and modified-dose medications were not included in the study analysis.
If the patient was started on a new medication by their PCP, the local compliance packaging pharmacy packed this medication in pill packs for the next 30-day box supply and sent pill bottles containing enough pills to last the patient till the next 30-day box. Every pill in the pill pack was coded with an identification number. If the patient's physician discontinued or changed the dose of any medication, the patient was advised to remove the pill from the pack using its identification number and either discard it or make the dose change accordingly.
A study investigator counted the pills left in the control group prior to the study start date. After the study start date, patients in the control group continued to receive their medications the same way they were getting them before being enrolled in this study using either electronic or printed prescriptions. They received instructions about the timing and frequency of medication administration from their physicians and nurses, and picked up their medications from their local pharmacy.
Patients from both groups had a follow-up PCP visit approximately four months from enrollment. Patients received telephone calls prior to their follow-up appointments to remind them to bring their medications from home. During the appointment, the study investigator counted the medications remaining in the pill packs for the study group patients and the pills remaining in pill bottles for the control group patients.
ExactCare provided the initial start date for each patient receiving their pill packs in 30-day supply. Refill dates were accessed from local pharmacies and the EMR for patients in the control group. This information was used to calculate the number of pills expected to remain with each patient at the end of the study and to compare to the actual number of pills remaining. New medications, discontinued medications, and modified-dose medications were not included in the study analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Medication Adherence
Medication Compliance
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Open label randomized controlled trial. The patient population included 114 patients, followed by primary care physicians at the Cleveland Clinic Stephanie Tubbs Jones Health Center, taking four or more medication doses daily. They were randomized either to the intervention group or the control group. Patients in the intervention group received prescriptions pre-packaged in individual packets that were delivered by the pharmacy. Patients in the control group continued to receive medications from pharmacies as they did prior to enrollment. The primary outcome was the percentage of missed pills in the intervention group versus the control group after four months of enrollment. The secondary outcome was the number of daily doses missed. The number and percentages of missed pills for each subject was calculated and summarized by group. The primary analysis compared the mean percentage of missed pills between the two groups using t-test analysis.
Primary Study Purpose
PREVENTION
Blinding Strategy
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-packed blisters for distribution of medications
Patients in the intervention group received prescriptions pre-packaged in individual packets that were delivered by the pharmacy.
Group Type
EXPERIMENTAL
Pre-packed blisters for distribution of medications
Intervention Type
BEHAVIORAL
Routine distribution of medications
Patients in the control group continued to receive medications from pharmacies as they did prior to enrollment.
Group Type
PLACEBO_COMPARATOR
Routine distribution of medications
Intervention Type
BEHAVIORAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pre-packed blisters for distribution of medications
Intervention Type
BEHAVIORAL
Routine distribution of medications
Intervention Type
BEHAVIORAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age of 18 years or older
* Covered by Medicaid insurance
* Seen in clinic at least two times within the past year, follow-up appointment scheduled between January and May 2015
* Prescribed a minimum of four medications daily
* Covered by Medicaid insurance
* Seen in clinic at least two times within the past year, follow-up appointment scheduled between January and May 2015
* Prescribed a minimum of four medications daily
Exclusion Criteria
* Nursing home patients
* Patients with planned hospital stays during the study period
* Patients who were already receiving medications in pre-packed blisters or pill packs prior to study enrollment
* Patients with planned hospital stays during the study period
* Patients who were already receiving medications in pre-packed blisters or pill packs prior to study enrollment
Minimum Eligible Age
18 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Huron Foundation
UNKNOWN
Sponsor Role
collaborator
The Cleveland Clinic
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrei Brateanu, MD
MD, Principal Investigator
Responsibility Role
PRINCIPAL_INVESTIGATOR
References
Explore related publications, articles, or registry entries linked to this study.
Ward BW, Schiller JS, Goodman RA. Multiple chronic conditions among US adults: a 2012 update. Prev Chronic Dis. 2014 Apr 17;11:E62. doi: 10.5888/pcd11.130389.
Reference Type
BACKGROUND
Ward BW, Schiller JS. Prevalence of multiple chronic conditions among US adults: estimates from the National Health Interview Survey, 2010. Prev Chronic Dis. 2013 Apr 25;10:E65. doi: 10.5888/pcd10.120203.
Reference Type
BACKGROUND
Blazing MA, Giugliano RP, Cannon CP, Musliner TA, Tershakovec AM, White JA, Reist C, McCagg A, Braunwald E, Califf RM. Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population. Am Heart J. 2014 Aug;168(2):205-12.e1. doi: 10.1016/j.ahj.2014.05.004. Epub 2014 May 15.
Reference Type
BACKGROUND
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2017 Dec 21;377(25):2506. doi: 10.1056/NEJMx170008. No abstract available.
Reference Type
BACKGROUND
Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, Ballantyne CM, Somaratne R, Legg J, Wasserman SM, Scott R, Koren MJ, Stein EA; Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015 Apr 16;372(16):1500-9. doi: 10.1056/NEJMoa1500858. Epub 2015 Mar 15.
Reference Type
BACKGROUND
Pasina L, Brucato AL, Falcone C, Cucchi E, Bresciani A, Sottocorno M, Taddei GC, Casati M, Franchi C, Djade CD, Nobili A. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014 Apr;31(4):283-9. doi: 10.1007/s40266-014-0163-7.
Reference Type
BACKGROUND
Marcum ZA, Gellad WF. Medication adherence to multidrug regimens. Clin Geriatr Med. 2012 May;28(2):287-300. doi: 10.1016/j.cger.2012.01.008.
Reference Type
BACKGROUND
Conn VS, Ruppar TM, Chan KC, Dunbar-Jacob J, Pepper GA, De Geest S. Packaging interventions to increase medication adherence: systematic review and meta-analysis. Curr Med Res Opin. 2015 Jan;31(1):145-60. doi: 10.1185/03007995.2014.978939. Epub 2014 Nov 4.
Reference Type
BACKGROUND
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 4;353(5):487-97. doi: 10.1056/NEJMra050100. No abstract available.
Reference Type
BACKGROUND
Ritchey M, Chang A, Powers C, Loustalot F, Schieb L, Ketcham M, Durthaler J, Hong Y. Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries - United States, 2014. MMWR Morb Mortal Wkly Rep. 2016 Sep 16;65(36):967-76. doi: 10.15585/mmwr.mm6536e1.
Reference Type
BACKGROUND
Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, Coker-Schwimmer EJ, Rosen DL, Sista P, Lohr KN. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012 Dec 4;157(11):785-95. doi: 10.7326/0003-4819-157-11-201212040-00538.
Reference Type
BACKGROUND
Stuart B, Davidoff A, Lopert R, Shaffer T, Samantha Shoemaker J, Lloyd J. Does medication adherence lower Medicare spending among beneficiaries with diabetes? Health Serv Res. 2011 Aug;46(4):1180-99. doi: 10.1111/j.1475-6773.2011.01250.x. Epub 2011 Mar 17.
Reference Type
BACKGROUND
Stuart BC, Dai M, Xu J, Loh FH, S Dougherty J. Does good medication adherence really save payers money? Med Care. 2015 Jun;53(6):517-23. doi: 10.1097/MLR.0000000000000360.
Reference Type
BACKGROUND
Wroe AL. Intentional and unintentional nonadherence: a study of decision making. J Behav Med. 2002 Aug;25(4):355-72. doi: 10.1023/a:1015866415552.
Reference Type
BACKGROUND
Gerber BS, Cho YI, Arozullah AM, Lee SY. Racial differences in medication adherence: A cross-sectional study of Medicare enrollees. Am J Geriatr Pharmacother. 2010 Apr;8(2):136-45. doi: 10.1016/j.amjopharm.2010.03.002.
Reference Type
BACKGROUND
Lafata JE, Karter AJ, O'Connor PJ, Morris H, Schmittdiel JA, Ratliff S, Newton KM, Raebel MA, Pathak RD, Thomas A, Butler MG, Reynolds K, Waitzfelder B, Steiner JF. Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes. J Gen Intern Med. 2016 Feb;31(2):188-195. doi: 10.1007/s11606-015-3486-0.
Reference Type
BACKGROUND
Bahrami H, Kronmal R, Bluemke DA, Olson J, Shea S, Liu K, Burke GL, Lima JA. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008 Oct 27;168(19):2138-45. doi: 10.1001/archinte.168.19.2138.
Reference Type
BACKGROUND
Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010 Feb 23;121(7):948-54. doi: 10.1161/CIRCULATIONAHA.109.192666. No abstract available.
Reference Type
BACKGROUND
Pi-Sunyer FX. Obesity and diabetes in blacks. Diabetes Care. 1990 Nov;13(11):1144-9. doi: 10.2337/diacare.13.11.1144.
Reference Type
BACKGROUND
Braverman J, Dedier J. Predictors of medication adherence for African American patients diagnosed with hypertension. Ethn Dis. 2009 Autumn;19(4):396-400.
Reference Type
BACKGROUND
Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med. 2007 Jan;120(1):26-32. doi: 10.1016/j.amjmed.2006.06.028.
Reference Type
BACKGROUND
Williams A, Manias E, Walker R. Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs. 2008 Jul;63(2):132-43. doi: 10.1111/j.1365-2648.2008.04656.x.
Reference Type
BACKGROUND
Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2002;(2):CD000011. doi: 10.1002/14651858.CD000011.
Reference Type
BACKGROUND
Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis. Prev Med. 2017 Jun;99:269-276. doi: 10.1016/j.ypmed.2017.03.008. Epub 2017 Mar 16.
Reference Type
BACKGROUND
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
https://www.cdc.gov/nchs/data/hus/hus13.pdf
Health US, 2013 With Special Feature on Prescription Drugs
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-1554
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
PlainLanguageRx: Improving Medication Labels to Reduce Health Disparities
NCT01622686
COMPLETED
NA
Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse
NCT03037112
COMPLETED
NA
PictureRx: An Intervention to Reduce Latino Health Disparities (Supplement: Medical Icons)
NCT01618461
COMPLETED
NA
An mHealth Intervention to Improve Medication Adherence and Health Outcomes
NCT04703439
COMPLETED
NA
Take 2 Pills and Go Volunteer in the Morning
NCT04038775
UNKNOWN
NA
Nurse-led Medication Self-management Intervention in the Improvement of Medication Adherence
NCT05645653
UNKNOWN
NA
Self-efficacy, Beliefs and Adherence- Pilot and Feasibility Trial of a Pharmacist-led Intervention
NCT03406923
COMPLETED
NA
Testing Interventions Designed to Improve How Members of the General Public Follow Instructions to Take Antibiotics
NCT07111754
NOT_YET_RECRUITING
NA
Oral Health Education Interventions Among Seniors
NCT03301714
COMPLETED
NA
A Randomized Controlled Trial to Improve Medication Compliance Among Patients With Coronary Heart Disease
NCT00208832
COMPLETED
NA
Improving Medication Adherence Through SMS (Short Messaging Service) in Adult Stroke Patients: a Randomised Controlled Behaviour Intervention Trial
NCT01986023
COMPLETED
NA
Effect of Reminders on Adherence
NCT02411006
COMPLETED
NA
The Impact of Text Messaging on Medication Adherence and Exercise Regimen Among Post-myocardial Infarction Patients
NCT02783287
COMPLETED
NA
Evaluating CVD Medication Adherence Program in Low SES
NCT02375737
COMPLETED
NA
The Drug Facts Box: Helping Consumers Understand Drugs for Risk Reduction
NCT00753857
COMPLETED
PHASE3
Investigation of a Patient Support Intervention for Statin Medication Adherence
NCT06972979
NOT_YET_RECRUITING
NA
Piloting an Intervention for Improving Treatment Adherence
NCT02250235
COMPLETED
NA
Increasing Adherence to Treatment Recommendations Following a Cardiac Event
NCT02327260
COMPLETED
NA
Enhanced Prescription Drug Label to Improve Patient Understanding and Use
NCT00973180
COMPLETED
NA
My Health - My Medication. Patient Involvement in Administration of Medication
NCT02894814
COMPLETED
NA
Social Forces to Improve Statin Adherence (Study B)
NCT02148523
COMPLETED
NA
Social Engagement Strategies to Improve Medication Adherence
NCT03734887
TERMINATED
NA
Smartphone Message to Improve the Drug Compliance in Pregnant Women.
NCT04295265
UNKNOWN
NA
Testing the Effects of a Text Message Caregiver Support Intervention for Latinos
NCT06728436
RECRUITING
NA
Online Education Intervention to Reduce Ageism Among Undergraduate Students
NCT04570917
COMPLETED
NA